Samumed is a pharmaceutical platform company focused on advancing regenerative medicine and oncology applications through research and innovation. The Company has discovered new targets and biological processes in the Wnt pathway, allowing the team to develop small molecule drugs that potentially address numerous degenerative conditions as well as many forms of cancer.